维维股份(600300.SH)：拟1亿元设立子公司维维生物科技

Core Viewpoint - The company, Weiweijia (维维股份), plans to invest 100 million RMB to establish a wholly-owned subsidiary, Weiweijia Biotechnology, to optimize resource allocation and enhance core business strategy [1] Group 1: Investment and Strategic Goals - The investment aims to deepen the core business strategic layout and improve market operation efficiency [1] - Establishing the subsidiary is aligned with the company's long-term development plan and is expected to lead the business to a higher value dimension [1] - The move is intended to continuously consolidate and strengthen the company's core competitiveness, creating a high-level value creation platform [1]